U.S. market to reach USD 3.82 billion and Europe USD 2.91 billion by 2035, supported by rising genomic diagnostics, precision medicine, and advanced sequencing adoption.

Austin, United States, Aug. 31, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The global Whole Exome Sequencing Market was valued at USD 2.22 billion in 2025 and is projected to reach USD 10.24 billion by 2035, expanding at a CAGR of 16.70% from 2026 to 2035, according to SNS Insider. Growth is being supported by the increasing use of precision medicine, genomic diagnostics, next-generation sequencing technologies, and bioinformatics across oncology, rare disease diagnosis, pharmacogenomics, and drug discovery.

Whole exome sequencing (WES) enables researchers and clinicians to analyze protein-coding regions of the genome and identify genetic variants associated with diseases. Increasing integration of genomic information into clinical decision-making, together with improvements in sequencing automation and AI-enabled bioinformatics, is expanding the potential application of WES across healthcare and life sciences.

Download the Whole Exome Sequencing Market Sample Report: https://www.snsinsider.com/sample-request/10176

Precision Medicine and Genomic Diagnostics Strengthen WES Demand

The transition from conventional symptom-based treatment toward precision medicine is becoming an important structural growth factor for the whole exome sequencing industry. WES allows researchers and healthcare professionals to identify disease-related genetic mutations and use genomic information to support diagnosis and individualized treatment strategies.

Large-scale genomic research programs are also contributing to the expansion of sequencing datasets and clinical genomics research. At the same time, growing attention to cancer, inherited disorders, and rare diseases is increasing demand for genomic technologies capable of identifying clinically relevant variants.

Adoption is further supported by next-generation sequencing platforms, laboratory automation, cloud-based genomic analytics, and AI-powered bioinformatics tools. These technologies can improve sequencing workflows and support the interpretation of increasingly large genomic datasets.

Key Whole Exome Sequencing Market Insights

  • Global Market Size, 2025: USD 2.22 Billion
  • Global Market Forecast, 2035: USD 10.24 Billion
  • Global CAGR, 2026–2035: 16.70%
  • Leading Product: Consumables — 37.86% share in 2025
  • Leading Technology: Sequencing by Synthesis — 70.16% share
  • Leading Application: Cancer Diagnostics — 33.51% share
  • Leading End User: Academic & Research Institutes — 41.39% share
  • Leading Workflow: Sequencing — 45.45% share
  • Largest Region: North America — approximately 44.75% share in 2025
  • Asia-Pacific CAGR: 18.30% through 2035

Market Segmentation

By Product: In 2025, the largest market segment by revenue was Consumables, which amounted to 37.86%, comprising sequencing kits, reagents, library preparation kits, and assay panels, used in all steps of the sequencing process. Software & Bioinformatics Solutions was the fastest growing product segment, owing to the increased requirement for sophisticated software for analyzing large volumes of data generated through whole exome sequencing.

By Technology: Sequencing By Synthesis has held dominance at 70.16%, being the most widespread technology because of its efficiency and scalability and the compatibility that it offers with existing next-generation sequencing platform. Nanopore Sequencing has the highest growth potential for the technology due to its fast processing, portable nature, and generation of long reads with least sample preparation.

By Application: Cancer Diagnostics had the highest market share, contributing to approximately 33.51%, mainly because of rising adoption of exome sequencing for profiling tumors, detecting mutations, and choosing appropriate treatments for oncology in various clinical applications. The Personalized Medicine segment will register the fastest growth rate because of the rising importance of genetic data for designing individualized treatment options.

By End User: The Academic and Research Institutes have the highest market share of almost 41.39%, owing to a number of factors such as genomic research studies, government funding, and large-scale sequencing of the genetics for disease and population genetics. The hospitals and clinics segment is growing at the fastest pace due to the adoption of genomic testing in diagnosis.

Regional Analysis:

North America was about 44.75% in 2025, attributed to a very advanced genomics & health care ecosystem, major contribution by prominent sequencing technologies providers and extensive use of precision medicine. There will be consistent growth in CMS reimbursement for next-generation genomic tests for the diagnosis of oncology and rare diseases, with extensive collaborations between academic institutions and biotech companies driving adoption of WES.

The U.S. Whole Exome Sequencing Market Size was estimated at around USD 0.85 billion in 2025, and would reach around USD 3.82 billion by 2035, growing at a CAGR of 18.18% during 2026-2035. U.S. continues to remain as the largest market in the world because of advanced infrastructure for healthcare and biotechnology industry along with ample funding from NIH.

The size of the Europe Whole Exome Sequencing Market was valued at USD 0.64 Billion in 2025 and projected to rise to USD 2.91 Billion by 2035, growing at a CAGR of 16.20% during the forecast period from 2026 to 2035, accounting for a market share of about 29.0%. Europe accounted for the second-largest revenue generator among all regions in the world due to sound healthcare infrastructure and national genomics programs, led by Germany, the UK, and France.

The Asia Pacific region is projected to witness a high CAGR of 18.30% till 2035, owing to rising infrastructure in genomics healthcare, increasing use of precision medicines, and high government spending in biotech companies. China accounts for about 55% of the revenue generated in the region owing to the priority given to genomics by the National Development and Reform Commission of China.

Buy the Whole Exome Sequencing Market Report with Competitive Analysis and 2035 Forecast: https://www.snsinsider.com/checkout/10176

Leading Market Players Listed in this Report are:

  • Illumina
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Roche
  • QIAGEN
  • BGI Genomics
  • PerkinElmer
  • Macrogen
  • Eurofins Genomics
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Bio-Rad Laboratories
  • Integrated DNA Technologies
  • Twist Bioscience
  • GATC Biotech
  • Novogene
  • PierianDx
  • WuXi AppTec
  • Genewiz (Azenta Life Sciences)
  • Personalis

Recent Developments:

  • 2026: Illumina expanded its next-generation sequencing ecosystem with enhanced high-throughput platforms and upgraded bioinformatics pipelines, improving turnaround time for clinical exome sequencing.
  • 2025: Thermo Fisher Scientific advanced its genomic solutions portfolio by expanding Ion Torrent sequencing systems and upgrading clinical sequencing workflows for improved scalability.

This Report Also Includes:

  • AI-driven bioinformatics platform and cloud-based genomic analytics adoption tracking
  • Regulatory approval pathway comparison across FDA, EU IVDR, and Asian markets
  • Reimbursement coverage expansion analysis for genomic testing across major healthcare systems

Exclusive Sections of the Report (The USPs):

  • PRECISION MEDICINE & GENOMIC DIAGNOSTICS ADOPTION METRICS – helps you understand the growing integration of whole exome sequencing into precision medicine, rare disease diagnosis, oncology, and personalized treatment pathways globally.
  • AI-DRIVEN BIOINFORMATICS & GENOMIC DATA ANALYTICS METRICS – helps you evaluate adoption trends in AI-powered variant interpretation, cloud-based genomic analytics, automation, and data-processing solutions across WES workflows.
  • CANCER & RARE DISEASE GENOMIC TESTING METRICS – helps you identify growth opportunities arising from the increasing use of whole exome sequencing for cancer profiling, inherited disorders, genetic variant detection, and clinical diagnostics.
  • SEQUENCING TECHNOLOGY & WORKFLOW PERFORMANCE METRICS – helps you assess technology adoption across sequencing-by-synthesis, nanopore, and other next-generation sequencing platforms, along with evolving sample preparation and sequencing workflows.
  • REGULATORY & REIMBURSEMENT COVERAGE METRICS – helps you track FDA, EU IVDR, and Asian regulatory pathways alongside reimbursement and insurance coverage expansion influencing clinical adoption of genomic testing.

Explore the Complete Whole Exome Sequencing Market Report: https://www.snsinsider.com/reports/whole-exome-sequencing-market-10176

Whole Exome Sequencing Market Report Scope

Report AttributesDetails
Market Size in 2025USD 2.22 Billion
Market Size by 2035USD 10.24 Billion
CAGRCAGR of 16.70% From 2026 to 2035
Base Year2025
Forecast Period2026-2035
Historical Data2022-2024
Key Segments• By Product (Consumables, Instruments, Services, Software & Bioinformatics Solutions, Others),
• By Technology (Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Nanopore Sequencing, SMRT Sequencing, Others),
• By Application (Cancer Diagnostics, Rare Disease Diagnosis, Personalized Medicine, Drug Discovery & Development, Others),
• By End User (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Others),
• By Workflow (Sequencing, Sample Preparation, Library Preparation, Data Analysis & Interpretation, Others)
Regional Analysis/CoverageNorth America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America).
CONTACT: About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315-961-9094 (US)
Email: info@snsinsider.com